Surrozen (SRZN) EBIT (2020 - 2026)
Surrozen (SRZN) posted quarterly EBIT of -$10.5 million for Q1 2026, down 9.48% year-over-year from -$11.6 million in Q1 2025, and up 17.27% quarter-over-quarter from -$12.6 million in Q4 2025.
Surrozen (SRZN) EBIT (2020 - 2026) Analysis & Trends
Surrozen's EBIT history runs 7 years deep, the most recent figure standing at -$10.5 million for Q1 2026.
- In Q1 2026, EBIT fell 9.48% year-over-year to -$10.5 million; the TTM figure through Mar 2026 stood at -$43.0 million (down 65.63% YoY), while the FY2025 annual figure was -$42.1 million, down 64.81% from the prior year.
- EBIT for Q1 2026 stood at -$10.5 million, up from -$12.6 million in the prior quarter.
- The five-year high for EBIT was $1.2 million in Q3 2024, with the low at -$14.6 million in Q1 2023.
- The 5-year median for EBIT is -$10.3 million (2023), against an average of -$9.9 million.
- The sharpest annual moves came in 2024 and 2025: EBIT soared 111.01% in 2024, then slumped 983.52% in 2025.
- Surrozen's EBIT stood at -$2.2 million in 2022, then tumbled by 348.32% to -$9.7 million in 2023, then rose by 11.64% to -$8.6 million in 2024, then tumbled by 47.1% to -$12.6 million in 2025, then advanced by 17.27% to -$10.5 million in 2026.
- Business Quant data shows SRZN's EBIT at -$10.5 million in Q1 2026, -$12.6 million in Q4 2025, and -$10.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 493.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 325.05 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -3,158.03 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 133.12 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 231.44 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.55 Mn |
| 10 | Surrozen | 281.63 Mn | 281.63 Mn | - | -10.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -10.37 Mn |
| Mar 31, 2026 | -10.46 Mn |
| Dec 31, 2025 | -12.64 Mn |
| Sep 30, 2025 | -10.89 Mn |
| Jun 30, 2025 | -9.02 Mn |
| Mar 31, 2025 | -9.55 Mn |
| Dec 31, 2024 | -8.59 Mn |
| Sep 30, 2024 | 1.23 Mn |
| Jun 30, 2024 | -9.05 Mn |
| Mar 31, 2024 | -9.13 Mn |
| Dec 31, 2023 | -9.72 Mn |
| Sep 30, 2023 | -11.19 Mn |
| Jun 30, 2023 | -10.28 Mn |
| Mar 31, 2023 | -14.59 Mn |
| Dec 31, 2022 | -2.17 Mn |
| Sep 30, 2022 | -13.61 Mn |
| Jun 30, 2022 | -14.07 Mn |
| Mar 31, 2022 | -14.49 Mn |
| Dec 31, 2021 | -15.00 Mn |
| Sep 30, 2021 | -13.71 Mn |